Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Pediatric | 9 | 2023 | 470 | 1.390 |
Why?
|
| Water-Electrolyte Imbalance | 3 | 2023 | 77 | 0.880 |
Why?
|
| Decision Trees | 2 | 2015 | 49 | 0.700 |
Why?
|
| Hospital Mortality | 5 | 2023 | 1013 | 0.650 |
Why?
|
| Heart Arrest | 2 | 2015 | 342 | 0.650 |
Why?
|
| Vasoconstrictor Agents | 1 | 2018 | 137 | 0.590 |
Why?
|
| Severity of Illness Index | 7 | 2021 | 2854 | 0.590 |
Why?
|
| Cardiotonic Agents | 1 | 2018 | 135 | 0.570 |
Why?
|
| Acute Kidney Injury | 4 | 2017 | 615 | 0.520 |
Why?
|
| Critical Illness | 7 | 2023 | 591 | 0.510 |
Why?
|
| Support Vector Machine | 1 | 2015 | 19 | 0.510 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 280 | 0.450 |
Why?
|
| Critical Care | 4 | 2023 | 648 | 0.420 |
Why?
|
| Biliary Atresia | 3 | 2023 | 186 | 0.380 |
Why?
|
| Liver Transplantation | 4 | 2023 | 1022 | 0.360 |
Why?
|
| Respiration, Artificial | 3 | 2023 | 458 | 0.340 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 478 | 0.330 |
Why?
|
| ROC Curve | 3 | 2018 | 558 | 0.280 |
Why?
|
| Multiple Organ Failure | 3 | 2021 | 140 | 0.280 |
Why?
|
| Models, Biological | 1 | 2011 | 1449 | 0.270 |
Why?
|
| Infant | 14 | 2023 | 12376 | 0.260 |
Why?
|
| Nursing Service, Hospital | 1 | 2005 | 1 | 0.240 |
Why?
|
| Nursing Evaluation Research | 1 | 2005 | 7 | 0.240 |
Why?
|
| Child, Preschool | 10 | 2023 | 13918 | 0.240 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2017 | 274 | 0.240 |
Why?
|
| Hospital Information Systems | 1 | 2005 | 43 | 0.240 |
Why?
|
| Child | 15 | 2023 | 24260 | 0.230 |
Why?
|
| Liver Cirrhosis | 4 | 2023 | 828 | 0.220 |
Why?
|
| Retrospective Studies | 14 | 2023 | 16068 | 0.220 |
Why?
|
| Heart Defects, Congenital | 3 | 2023 | 1803 | 0.210 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 1414 | 0.210 |
Why?
|
| Hypernatremia | 1 | 2023 | 29 | 0.200 |
Why?
|
| Hyponatremia | 1 | 2023 | 72 | 0.190 |
Why?
|
| Adolescent | 9 | 2023 | 19133 | 0.190 |
Why?
|
| Risk Factors | 7 | 2023 | 10035 | 0.180 |
Why?
|
| Patient Admission | 1 | 2021 | 184 | 0.180 |
Why?
|
| Natriuretic Agents | 2 | 2017 | 31 | 0.170 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 138 | 0.170 |
Why?
|
| Length of Stay | 4 | 2021 | 1290 | 0.170 |
Why?
|
| Perioperative Care | 1 | 2021 | 195 | 0.160 |
Why?
|
| End Stage Liver Disease | 1 | 2021 | 178 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2021 | 189 | 0.160 |
Why?
|
| Biliary Tract Diseases | 1 | 2018 | 34 | 0.150 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2018 | 67 | 0.150 |
Why?
|
| Ventilators, Mechanical | 1 | 2018 | 35 | 0.150 |
Why?
|
| Humans | 23 | 2023 | 123258 | 0.140 |
Why?
|
| Chlorothiazide | 1 | 2016 | 12 | 0.140 |
Why?
|
| Nephrons | 1 | 2016 | 20 | 0.140 |
Why?
|
| Male | 16 | 2023 | 60337 | 0.140 |
Why?
|
| Diuresis | 1 | 2016 | 58 | 0.140 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2018 | 145 | 0.130 |
Why?
|
| Female | 15 | 2023 | 65619 | 0.130 |
Why?
|
| Cost of Illness | 1 | 2017 | 243 | 0.120 |
Why?
|
| Hospitalization | 1 | 2023 | 1739 | 0.120 |
Why?
|
| Treatment Outcome | 7 | 2021 | 12169 | 0.120 |
Why?
|
| Area Under Curve | 1 | 2015 | 314 | 0.120 |
Why?
|
| Algorithms | 1 | 2002 | 1598 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2018 | 365 | 0.120 |
Why?
|
| Shock | 1 | 2015 | 90 | 0.120 |
Why?
|
| Linear Models | 1 | 2015 | 669 | 0.110 |
Why?
|
| Resuscitation | 1 | 2015 | 244 | 0.100 |
Why?
|
| Databases as Topic | 1 | 2011 | 71 | 0.090 |
Why?
|
| Prospective Studies | 2 | 2020 | 6030 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2114 | 0.090 |
Why?
|
| Seasons | 1 | 2011 | 305 | 0.080 |
Why?
|
| Waiting Lists | 1 | 2011 | 225 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2011 | 360 | 0.070 |
Why?
|
| Prognosis | 1 | 2017 | 4510 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2009 | 222 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2023 | 8114 | 0.070 |
Why?
|
| Ticlopidine | 1 | 2006 | 28 | 0.070 |
Why?
|
| Young Adult | 2 | 2021 | 8868 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2017 | 539 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3239 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2844 | 0.060 |
Why?
|
| Fibrinolytic Agents | 1 | 2006 | 198 | 0.060 |
Why?
|
| Time Factors | 2 | 2011 | 6222 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 5056 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1689 | 0.050 |
Why?
|
| Data Collection | 1 | 2005 | 383 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 171 | 0.050 |
Why?
|
| Sodium | 1 | 2023 | 294 | 0.050 |
Why?
|
| Thrombosis | 1 | 2006 | 518 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 234 | 0.050 |
Why?
|
| Disease Progression | 2 | 2018 | 2030 | 0.050 |
Why?
|
| Research Design | 1 | 2005 | 679 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2020 | 121 | 0.040 |
Why?
|
| Risk | 1 | 2002 | 747 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 865 | 0.040 |
Why?
|
| Ferritins | 1 | 2018 | 96 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2021 | 1473 | 0.040 |
Why?
|
| Heart-Assist Devices | 1 | 2006 | 1026 | 0.040 |
Why?
|
| Oliguria | 1 | 2017 | 19 | 0.030 |
Why?
|
| Furosemide | 1 | 2016 | 36 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2002 | 1171 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 254 | 0.030 |
Why?
|
| Cause of Death | 1 | 2018 | 463 | 0.030 |
Why?
|
| Diuretics | 1 | 2016 | 159 | 0.030 |
Why?
|
| Creatinine | 1 | 2017 | 382 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 726 | 0.030 |
Why?
|
| Age Factors | 1 | 2021 | 2811 | 0.030 |
Why?
|
| Texas | 2 | 2015 | 3558 | 0.030 |
Why?
|
| Heart Rate | 1 | 2017 | 587 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1099 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1049 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1142 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 781 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 2409 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2011 | 174 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 260 | 0.020 |
Why?
|
| Kidney | 1 | 2017 | 1343 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2019 | 4701 | 0.020 |
Why?
|
| United States | 1 | 2023 | 10652 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 3053 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2011 | 496 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2011 | 482 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2011 | 763 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2011 | 942 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2006 | 122 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 1123 | 0.020 |
Why?
|
| Warfarin | 1 | 2006 | 118 | 0.020 |
Why?
|
| Aspirin | 1 | 2006 | 220 | 0.010 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2006 | 214 | 0.010 |
Why?
|
| Adult | 1 | 2005 | 29100 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3336 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2006 | 854 | 0.010 |
Why?
|